AXA/2025/FY/Earnings presentation: Difference between revisions
Content deleted Content added
PlumBot: publish from draft |
Migrate infobox: document_type -> document_category; add specific form as document_type |
||
| (8 intermediate revisions by the same user not shown) | |||
Line 4:
| period = FY
| period_label = FY25
|
| publication_date = 2026-02-26
| language = English
| pages = 49
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| intro_sentence = This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.
}}
Line 19 ⟶ 18:
=== Full Year 2025 earnings presentation ===
* ''AXA Full Year 2025''
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
*
*
* ''Risk factors'' and uncertainties that may affect AXA's business are described in Part 5 "Risk Factors and Risk Management" of AXA's 2024 Universal Registration Document <sup>p. 2</sup>.
* ''Alternative performance measures'' (APMs) used include "underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
** APMs are defined under ESMA guidelines and the AMF's 2015 position statement, with reconciliations provided in AXA's 2025 Activity Report <sup>p. 2</sup>.
* ''Financial statements status'': AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of audit procedures <sup>p. 2</sup>.
=== Table of contents ===
*
*
*
== FY25 Highlights ==
* Section divider
=== Full Year 2025 | Excellent performance ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Metric
! class="col-m" style="text-align:right" | Value
|-
| style="text-align:left" | Revenues growth vs. FY24
| style="text-align:right" | +6%
|-
| style="text-align:left" | Underlying EPS growth vs. FY24
| style="text-align:right" | +8%
|-
| style="text-align:left" | Return on equity
| style="text-align:right" | 16%
|-
| style="text-align:left" | Solvency II ratio
| style="text-align:right" | 224%
|-
| style="text-align:left" | DPS growth
| style="text-align:right" | +8%
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | EUR 1.25bn
|-
| style="text-align:left" | Underlying EPS outlook for 2026
| style="text-align:right" | Upper end of 6%-8% target range
|}
</div>
* Dividend proposal based on Board of Directors' recommendation on February 25, 2026, subject to Shareholders' Annual General Meeting approval on April 30, 2026
* Share buyback approved by the Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions
=== Executing the plan on growth, margin and efficiency ===
Line 57 ⟶ 80:
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Change (excluding AXA IM)
|-
| style="text-align:left" | Underlying earnings
Line 63 ⟶ 87:
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
| style="text-align:right" | +9%
|}
</div>
*
* Record profitability:
* Scaling the business:
* Consistent earnings growth
=== Diversified franchise, well positioned in an attractive industry ===
Line 75 ⟶ 99:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 87 ⟶ 111:
| style="text-align:left" | Large & Specialty
| style="text-align:right" | 17%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|}
</div>
*
* ''Our right to win'' is supported by four strategic pillars:
** Leading brand & high customer NPS
** Strong and diversified distribution
** Technical expertise to price & underwrite risks
** Scale offering cost advantage
=== Laying the foundation for the next plan ===
* ''Strategic pillars'' established to lay the foundation for the next plan:
** ''
** ''
** ''
** ''Building resilience'
* ''Earnings growth'' outlook supported by strong foundations, providing confidence in sustaining earnings growth <sup>p. 8</sup>
==
=== FY25 business performance ===
* ''Section 2'': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
=== Strong delivery across our businesses ===
* ''Premium growth basis'': change for gross written premiums is at constant scope and FX <sup>p. 10</sup>.
* ''Earnings growth basis'': change for underlying earnings is at constant FX <sup>p. 10</sup>.
* ''Total GWP definition'': FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
<div style="overflow-x:auto">
{| class="wikitable
|+ Gross written premiums and underlying earnings by region FY25 <sup>p. 10</sup>
! style="text-align:left" |
! class="col-
! class="col-
|-
| style="text-align:left" | ''France'' (27% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | +
|-
| style="text-align:left" | ''Europe'' (38% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | +
|-
| style="text-align:left" | ''AXA XL'' (17% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | +
|-
| style="text-align:left" | ''Asia, Africa & EME-LATAM'' (18% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | +
|}
</div>
=== P&C | Strong margins, confidence in sustaining growth ===
*
**
* ''Underlying earnings'' +9% at constant FX to EUR 5.9bn <sup>p. 11</sup>.
* ''Retail and SME & Mid-market'' strategic outlook:
** ''
** ''Beyond 2025'': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>.
* ''AXA XL (Large & Specialty)'' strategic outlook:
** ''
** ''Beyond 2025'': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>.
* ''Earnings drivers'' supporting performance:
**
**
** Data & AI to further enhance customer experience and technical excellence <sup>p. 11</sup>.
=== L&H | Good momentum, well positioned to capture growth opportunities ===
* ''Gross written premiums'' (GWP) reached EUR 57bn <sup>p. 12</sup>.
* (donut) ''GWP mix'': Short-term and Long-term segments — shares not labeled <sup>p. 12</sup>.
* ''Long-term business'' strategic priorities:
** ''2025'': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>.
** ''Beyond 2025'': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>.
* ''Short-term business'' strategic priorities:
** ''2025'': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>.
** ''Beyond 2025'': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>.
* ''Strategic levers'' for growth and efficiency:
** Focus on cost reduction <sup>p. 12</sup>.
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>.
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>.
== Financial Performance ==
=== FY25
* ''Section
=== P&C | Continued disciplined growth ===
Line 213 ⟶ 216:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C GWP & other revenues by
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Commercial lines
| style="text-align:right" |
| style="text-align:right" | 35.8
| style="text-align:right" | +4%
Line 229 ⟶ 232:
|-
| style="text-align:left" | AXA XL Reinsurance
| style="text-align:right" |
| style="text-align:right" | 2.6
| style="text-align:right" | +8%
Line 236 ⟶ 239:
|-
| style="text-align:left" | Retail lines
| style="text-align:right" |
| style="text-align:right" | 19.7
| style="text-align:right" | +7%
Line 250 ⟶ 253:
|}
</div>
* Continued pricing momentum and volume growth in Mid-market and SME
*
*
*
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
Line 259 ⟶ 262:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
| style="text-align:right" | 67.4%
| style="text-align:right" | 67.0%
|-
| style="text-align:left" | Expense ratio
| style="text-align:right" | 25.0%
| style="text-align:right" | 24.8%
|-
| style="text-align:left" | Nat Cat
| style="text-align:right" | 3.8%
| style="text-align:right" | 3.4%
|-
| style="text-align:left" | Prior year reserve development
| style="text-align:right" | -1.6%
| style="text-align:right" | -1.1%
|-
| style="text-align:left" | Discount
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5%
|-
| style="text-align:left; font-weight:bold" |
| style="text-align:right; font-weight:bold" | 91.0%
| style="text-align:right; font-weight:bold" | 90.6%
|}
</div>
* Undiscounted CY loss ratio (ex Nat Cat) improved from:
**
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management
* Expense ratio improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology
* Nat Cat charges below normalized load
* Prior year reserve development shows lower reliance
* Reserve prudence enhanced by taking advantage of a good year
=== P&C | Earnings growth from higher underwriting and financial result ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Underlying earnings
Line 333:
|}
</div>
*
* Underwriting result improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence.
* Investment income increased reflecting higher volumes and better reinvestment yields on fixed income assets.
* Insurance finance expenses impacted by higher unwind of discount of claims reserves, in line with guidance.
* Forex impact was unfavorable, notably due to USD depreciation vs. EUR.
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 339 ⟶ 343:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
Line 345 ⟶ 349:
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" |
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
Line 370 ⟶ 374:
| style="text-align:right" | -7%
|-
| style="text-align:left
| style="text-align:right" | 17.5
| style="text-align:right" | 19.0
Line 388 ⟶ 387:
| style="text-align:right" | —
| style="text-align:right" | 8.5
| style="text-align:right" | +4%
|-
| style="text-align:left" | Employee Benefits GWP
| style="text-align:right" | —
| style="text-align:right" | 12.9
| style="text-align:right" | +4%
|}
Line 394 ⟶ 398:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows by
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
Line 400 ⟶ 404:
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" |
| style="text-align:right; font-weight:bold" |
|-
| style="text-align:left" | Protection
| style="text-align:right" | —
| style="text-align:right" |
|-
| style="text-align:left" | Health
| style="text-align:right" | —
| style="text-align:right" |
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | —
| style="text-align:right" |
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | —
| style="text-align:right" |
|-
| style="text-align:left" | Traditional G/A
Line 426 ⟶ 430:
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ PVEP trend by
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
Line 439:
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left; font-weight:bold" | Total PVEP
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
Line 482:
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
| style="text-align:right" |
|}
</div>
* ''PVEP'' impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>.
* ''NB CSM'' driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>.
* ''NBV'' broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>.
* ''NBV margin'': 4.4% in FY24 → 4.5% in FY25 <sup>p. 18</sup>
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 493 ⟶ 497:
|+ Contractual Service Margin rollforward, FY24 to FY25 <sup>p. 19</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | FY24
Line 521 ⟶ 525:
</div>
*
*
*
*
* (waterfall) ''Contractual Service Margin rollforward'' (in EUR billion): FY24 EUR 33.6bn (o/w Life EUR 25.8bn, o/w Health EUR 7.7bn) → New business CSM +EUR 2.2bn → Underlying return on in-force +EUR 1.3bn → CSM release -EUR 3.0bn (Normalized CSM growth +2%) → Economic variance +EUR 0.6bn → Operating variance -EUR 0.3bn → Affiliates, FX & other -EUR 1.4bn → FY25 EUR 33.0bn (o/w Life EUR 25.4bn, o/w Health EUR 7.6bn) <sup>p. 19</sup>
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 532 ⟶ 535:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | FY24 start
| style="text-align:right" | 3,323
|-
| style="text-align:left" | Short-term technical margin
| style="text-align:right" | +60
|-
| style="text-align:left" | Long-term result incl. CSM release
| style="text-align:right" | +156
|-
| style="text-align:left" | Financial result
| style="text-align:right" | -11
|-
| style="text-align:left" | Tax, FX and others
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
* ''Underlying earnings'' +7% LFL to EUR 3,501m <sup>p. 20</sup>
* ''
* ''
* ''
*
* ''Life underlying earnings'' +4% to EUR 2.7bn (prior: EUR 2.6bn) <sup>p. 20</sup>
* ''Health underlying earnings'' +17% to EUR 0.8bn (prior: EUR 0.7bn) <sup>p. 20</sup>
* ''Short-term margin'' strong on underwriting and claims initiatives; more than offset legislative change on Mexico VAT recoverability of EUR -0.1bn <sup>p. 20</sup>
* ''Long-term results'' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins <sup>p. 20</sup>
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
Line 594 ⟶ 573:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Property & Casualty
Line 618 ⟶ 597:
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
| style="text-align:right" | -
|-
| style="text-align:left" | ''Underlying earnings''
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
|-
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | +2.1
| style="text-align:right" | —
|-
| style="text-align:left;
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Financial flows (incl. RCG)
| style="text-align:right" | +0.3
| style="text-align:right" | -0.7
| style="text-align:right" | —
|-
| style="text-align:left" | ''Net income''
| style="text-align:right" | 7.9
| style="text-align:right" | 9.8
| style="text-align:right" | +26%
|}
</div>
Line 629 ⟶ 628:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | FY24
| style="text-align:right" | 3.59
|-
| style="text-align:left" | Earnings growth
Line 641 ⟶ 643:
| style="text-align:left" | Forex
| style="text-align:right" | -2%
|-
| style="text-align:left" | Temporary earnings dilution from AXA IM sale
| style="text-align:right" | -1%
|-
| style="text-align:left" | FY25
| style="text-align:right" | 3.86
|}
</div>
* ''Underlying earnings'' drivers:
**
**
*
** Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
**
*
*
=== Shareholders'
* (stacked bar) ''Shareholders' equity'' Group share:
** ''FY24'': EUR 49.9bn total (comprising SHE excl. OCI EUR 58.0bn and Net OCI EUR -8.1bn) <sup>p. 22</sup>
** ''FY25'': EUR 47.2bn total (comprising SHE excl. OCI EUR 54.0bn and Net OCI EUR -6.8bn) <sup>p. 22</sup>
* ''SHE (excl. OCI & undated subordinated debt)'': EUR 53.2bn in FY24 → EUR 47.0bn in HY25 → EUR 49.4bn in FY25 <sup>p. 22</sup>
* ''Debt gearing'': 20.6% in FY24 → 23.4% in HY25 → 22.3% in FY25 <sup>p. 22</sup>
* ''Underlying ROE'': 15.2% in FY24 → 17.5% in HY25 → 16.0% in FY25 <sup>p. 22</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" | ''Opening
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Net income for the period
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" |
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" |
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt (including interest charges)
| style="text-align:right" | -0.3
| style="text-align:right" | -1.2
Line 737 ⟶ 712:
| style="text-align:left" | Other
| style="text-align:right" | -0.6
| style="text-align:right" |
|-
| style="text-align:left" | ''Closing
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
Line 747 ⟶ 722:
=== Higher organic cash remittance and robust cash position at Holding ===
* (bar) ''Net cash remittance'' trend:
** ''FY24'': EUR 7.7bn total, comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>
* ''Remittance ratio'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Holding cash position bridge FY24 to FY25 in Euro billion <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | ''FY24 Cash position''
| style="text-align:right" | 4.0
|-
Line 790 ⟶ 745:
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Holding costs
| style="text-align:right" | -1.3
|-
Line 802 ⟶ 757:
| style="text-align:right" | +3.1
|-
| style="text-align:left" | ''FY25 Cash position''
| style="text-align:right" | 5.6
|}
Line 813 ⟶ 768:
|+ Solvency II walk, FY24 to FY25 <sup>p. 24</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Solvency II ratio (pts)
|-
Line 858 ⟶ 813:
|}
</div>
* Foreseeable dividends accounted for -EUR 4.8bn.
* Provision for annual share buyback for 2026 accounted for -EUR 1.25bn.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities of Solvency II
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
Line 880 ⟶ 838:
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity (excluding PE & Infra) +25%
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity (excluding PE & Infra) -25%
| style="text-align:right" | +2
|-
Line 896 ⟶ 854:
|}
</div>
* Euro sovereign spreads sensitivity assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve, applied on sovereign and quasi-sovereign exposures.
* Credit rating migration sensitivity assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
Line 903 ⟶ 862:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II ratio
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Solvency II ratio as of December 31, 2025
| style="text-align:right" | 224
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -
|-
| style="text-align:left" | Solvency II
| style="text-align:right" |
|}
</div>
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026.
*
* Provides additional capital flexibility.
* Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* ''Grandfathering end impact'' on January 1, 2026 is -10pts to 215% <sup>p. 25</sup>.
=== Thomas Buberl, Group CEO conclusion ===
* ''
=== Conclusion ===
*
*
*
*
=== February 26, 2026 Q&A Full Year 2025 earnings ===
* ''
=== AXA Investor Relations | Keep in touch ===
* ''Investor Relations contact'': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup>
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" | Date
! class="col-m" style="text-align:right" | Event
! class="col-m" style="text-align:right" | Location
|-
| style="text-align:left" | March
| class="col-m" style="text-align:right" | Roadshows
| class="col-m" style="text-align:right" | Europe and US
|-
| style="text-align:left" | May 5
| class="col-m" style="text-align:right" | 1Q25 Activity Indicators
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2
| class="col-m" style="text-align:right" | BNP Paribas Exane CEO Conference
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2-4
| class="col-m" style="text-align:right" | Goldman Sachs European Financials Conference
| class="col-m" style="text-align:right" | Zurich
|-
| style="text-align:left" | July 31
| class="col-m" style="text-align:right" | HY26 Earnings Release
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | September 21
| class="col-m" style="text-align:right" | AXA Investor Day
| class="col-m" style="text-align:right" | London
|}
</div>
== Appendices ==
*
=== Table of contents ===
* ''
* ''Additional P&C disclosures'
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Jan 1st 2026
|-
| style="text-align:left" | Tier 1
| style="text-align:right" | 4.8
| style="text-align:right" | 4.6
| style="text-align:right" | 3.2
|-
| style="text-align:left" | Tier 2
| style="text-align:right" | 10.8
| style="text-align:right" | 12.2
| style="text-align:right" | 11.3
|-
| style="text-align:left" | Senior debt
| style="text-align:right" | 3.5
| style="text-align:right" | 3.5
| style="text-align:right" | 5.8
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 19.2
| style="text-align:right; font-weight:bold" | 20.3
| style="text-align:right; font-weight:bold" | 20.3
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 22.3%
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual maturity breakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2028
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | 10.8
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.6
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (contractual)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 1.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | 2027
| style="text-align:right" | —
| style="text-align:right" | 2.4
| style="text-align:right" | —
|-
| style="text-align:left" | 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | —
| style="text-align:right" | 2.0
| style="text-align:right" | —
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | 6.4
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.0
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (economic)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 0.8
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
* In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating (issued January 2005).
* Economic maturity accounts for the first date of step-up calls on institutionally placed subordinated debt.
* For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained for economic maturity.
=== General account invested assets ===
* ''Total General Account'' invested assets at EUR 450bn <sup>p. 33</sup>.
* ''Duration gap'' at -0.4 year <sup>p. 33</sup>.
* (donut) ''FY25 General Account invested assets'': EUR 450bn total; mix includes Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>.
* ''Other fixed income'' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>.
* ''Listed equities'' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>.
* ''Private equity and hedge funds'' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Invested assets breakdown FY25 <sup>p. 33</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | %
|-
| style="text-align:left" | ''Fixed income''
| style="text-align:right" | 345
| style="text-align:right" | 77%
|-
| style="text-align:left
| style="text-align:right" | 167
| style="text-align:right" | 37%
|-
| style="text-align:left
| style="text-align:right" | 121
| style="text-align:right" | 27%
|-
| style="text-align:left
| style="text-align:right" | 56
| style="text-align:right" | 13%
|-
| style="text-align:left" | ''Real estate''
| style="text-align:right" | 41
| style="text-align:right" | 9%
|-
| style="text-align:left" | ''Infrastructure equity''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Listed equities''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Private equity and hedge funds''
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" | ''Cash''
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" | ''Policy loans''
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|}
</div>
=== Structured and
* ''Total structured and private credit assets'' stood at EUR 69bn, representing 15% of the total General Account portfolio, with 54% participating <sup>p. 34</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Structured and
! style="text-align:left" | Invested assets (100%) in EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | % of total G/A¹ portfolio
! class="col-m" style="text-align:right" | Comments
|-
| style="text-align:left" | Residential Mortgages
| style="text-align:right" | 16
| style="text-align:right" | 4%
| style="text-align:right" | - EUR 6bn Dutch mortgages, NHG guaranteed - EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
|-
| style="text-align:left" | CLO & ABS
| style="text-align:right" | 25
| style="text-align:right" | 6%
| style="text-align:right" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Skewed towards resilient industries (Telecom, Utilities, Transport)
|-
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
|-
| style="text-align:left" | Mid-Market lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | o/w 54% participating
|}
</div>
* ''General Account'' (G/A) represents the investment portfolio <sup>p. 34</sup>.
=== Investment portfolio | Fixed income reinvestment ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment asset mix <sup>p. 35</sup>
! style="text-align:left" |
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21%
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7%
|}
</div>
Line 1,122 ⟶ 1,266:
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment Yield <sup>p. 35</sup>
! style="text-align:left" |
! class="col-s" style="text-align:right" | Yield
|-
Line 1,136 ⟶ 1,280:
</div>
* Fixed income reinvestment
* Reinvestment yield achieved at 3.9% on EUR 57bn fixed income <sup>p. 35</sup>
** Average duration of 9 years <sup>p. 35</sup>
** Private & Structured Credit reinvestment of EUR 19.7bn at 4.7% yield, including CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY <sup>p. 35</sup>
** Strategic shift characterized by a gradual transition from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
=== Table of contents ===
* ''
* ''Additional P&C disclosures'
* ''Additional IFRS17 disclosures'' on page 41 <sup>p. 36</sup>
* ''Sustainability'' on page 44 <sup>p. 36</sup>
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 1,149 ⟶ 1,297:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by line of business
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Casualty
| style="text-align:right" | 35%
|-
| style="text-align:left" | Property
| style="text-align:right" | 29%
|-
| style="text-align:left" | Specialty
| style="text-align:right" | 19%
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by geography <sup>p. 37</sup>
! style="text-align:left" | Geography
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Americas
| style="text-align:right" | 46%
|-
| style="text-align:left" | Europe & APAC
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:right" | 19%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" | Line of business
! class="col-m" style="text-align:right" | Profitability
! class="col-m" style="text-align:right" | Ex-price growth
|-
| style="text-align:left" | Property
| class="col-m" style="text-align:right" | high
| class="col-m" style="text-align:right" | high
|-
| style="text-align:left" | Specialty
| class="col-m" style="text-align:right" | medium-high
| class="col-m" style="text-align:right" | medium-high
|-
| style="text-align:left" | Casualty
| class="col-m" style="text-align:right" | medium
| class="col-m" style="text-align:right" | medium
|-
| style="text-align:left" | Professional lines
| class="col-m" style="text-align:right" | lower
| class="col-m" style="text-align:right" | lower
|}
</div>
* Business diversification is well balanced across lines of business and geographies <sup>p. 37</sup>
* Market leadership positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
** Multinational Programs <sup>p. 37</sup>
** Marine <sup>p. 37</sup>
** Fine Art & Specie <sup>p. 37</sup>
* Cycle management is utilized to deliver consistent profitability <sup>p. 37</sup>
* ''Property'': high profitability, high ex-price growth <sup>p. 37</sup>
* ''Specialty'': medium-high profitability, medium-high ex-price growth <sup>p. 37</sup>
* ''Casualty'': medium profitability, medium ex-price growth <sup>p. 37</sup>
* ''Professional lines'': lower profitability, lower ex-price growth <sup>p. 37</sup>
=== P&C | Focus on
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims and technical reserves
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY18
Line 1,208 ⟶ 1,383:
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Claims reserves ratio (IFRS4 basis)
| style="text-align:right" | 179
| style="text-align:right" | 185
| style="text-align:right" | 193
| style="text-align:right" | 188
| style="text-align:right" | 189
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Claims reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 198
| style="text-align:right" | 195
| style="text-align:right" | 180
| style="text-align:right" | 175
|-
| style="text-align:left" | Technical reserves ratio (IFRS4 basis)
| style="text-align:right" | 213
| style="text-align:right" | 227
| style="text-align:right" | 233
| style="text-align:right" | 226
| style="text-align:right" | 227
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Technical reserves ratio (IFRS17 basis)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 234
| style="text-align:right" | 232
| style="text-align:right" | 216
| style="text-align:right" | 210
|}
</div>
* Technical reserves definition includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
=== P&C | 2026 Simplified Group Nat Cat
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Insurance segment
! style="text-align:left" | EUR
! class="col-s" style="text-align:right" | Retention
! class="col-m" style="text-align:right" | Capacity
|-
| style="text-align:left" | EU Windstorm
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Europe Flood
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Europe Earthquake
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | NA Hurricane
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | NA Earthquake
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Per other perils
| style="text-align:right" |
| style="text-align:right" |
|}
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
* (diagram) ''Reinsurance segment'' (illustrative):
*
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
Line 1,298 ⟶ 1,468:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | 1/20y (95th percentile)
Line 1,312 ⟶ 1,482:
|-
| style="text-align:left" | Median (50th percentile)
| style="text-align:right" | +0.1
|-
| style="text-align:left" | 1/5y (20th percentile)
| style="text-align:right" | +0.5
|-
| style="text-align:left" | 1/10y (10th percentile)
| style="text-align:right" | +0.7
|-
| style="text-align:left" | 1/20y (5th percentile)
| style="text-align:right" | +0.8
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable
|+
! style="text-align:left" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | 2025
| class="col-s" style="text-align:right" | 2.6
| class="col-s" style="text-align:right" | ca. 4.5%
|-
| style="text-align:left" |
| class="col-s" style="text-align:right" | 2.
| class="col-s" style="text-align:right" |
|}
</div>
* ''More severe years'' result in a negative deviation in ca. 40% of cases <sup>p. 40</sup>.
* ''Less severe years'' result in a positive deviation in ca. 60% of cases <sup>p. 40</sup>.
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). <sup>p. 40</sup>
=== Table of contents ===
* ''
* ''Additional P&C disclosures'' <sup>p. 36</sup>
=== P&C | Margin analysis ===
Line 1,353 ⟶ 1,526:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | 2,778
| style="text-align:right" | +707
|-
| style="text-align:left" | ''Current Accident Year Discounting''
| style="text-align:right" | 2,009
| style="text-align:right" | +115
|-
| style="text-align:left" | ''Prior Years' Reserve Development (PYD)''
| style="text-align:right" | 622
| style="text-align:right" | -341
|-
| style="text-align:left" | ''Investment Income''
| style="text-align:right" | 3,988
| style="text-align:right" | +435
|-
| style="text-align:left" | ''Insurance Finance Expenses''
| style="text-align:right" | -1,358
| style="text-align:right" | -235
|-
| style="text-align:left" | ''Underlying Earnings before tax''
| style="text-align:right" | 8,040
| style="text-align:right" | +681
Line 1,370 ⟶ 1,563:
| style="text-align:right" | -10
|-
| style="text-align:left" | ''Underlying
| style="text-align:right" | 5,872
| style="text-align:right" | +501
Line 1,376 ⟶ 1,569:
</div>
* ''Gross earned premiums'' EUR 57,656m (+6%) <sup>p. 42</sup>
* ''Undiscounted combined ratio'' 95.2% (-1.0pt); of which Nat Cats was 3.4% (-0.4pt) <sup>p. 42</sup>
* ''Discounting ratio'' -3.5% (+0.0pt in Combined Ratio points) <sup>p. 42</sup>
* ''Net claims reserves'' for current accident year at EUR 19.0bn; duration of 4.0 years; discount rate of 2.8% <sup>p. 42</sup>
* ''PYD ratio'' -1.1% (+0.7pt) <sup>p. 42</sup>
* ''Average assets'' for FY25 at EUR 115bn; asset book yield at 3.5%; reinvestment yield on fixed income assets at 4.3% <sup>p. 42</sup>
* ''Reserves at locked-in rate'' for FY24 at EUR 71bn; liability book yield at 1.9% <sup>p. 42</sup>
* ''Underlying earnings growth'' +9% vs. FY24 at constant FX <sup>p. 42</sup>
* ''Discount rate sensitivity'': FY25 sensitivity to current accident year discount rate changes (parallel shift of the full-year average yield curve):
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
* ''Insurance finance expenses'': 2026e pre-tax expected at ~EUR -1.4bn <sup>p. 42</sup>
** Sensitivity of 2026e expenses to changes in 2025 current AY discount: +25bps ~EUR -50m; -25bps ~EUR +50m <sup>p. 42</sup>
=== L&H | Margin analysis ===
* ''L&H margin analysis'' includes scope impact <sup>p. 43</sup>.
* ''Short-term technical margin'' +EUR 60m to EUR 479m, including the recapture of Laya <sup>p. 43</sup>.
* ''Gross earned premiums'' +10% to EUR 17,416m <sup>p. 43</sup>.
* ''All year combined ratio'' 97.2%, improved 0.1pts <sup>p. 43</sup>.
* ''Long-term technical margin'' +EUR 156m to EUR 2,804m <sup>p. 43</sup>.
** ''CSM release'' +EUR 215m to EUR 2,954m <sup>p. 43</sup>.
** ''Technical experience'' decreased EUR 58m to EUR -150m <sup>p. 43</sup>.
* ''Investment income'' (non-VFA only) decreased EUR 1m to EUR 2,484m <sup>p. 43</sup>.
** ''Average assets'' (FY25) at EUR 98bn with an asset book yield of 2.5% and FY25 reinvestment yield on fixed income assets of 3.8% <sup>p. 43</sup>.
* ''Insurance finance expenses'' (non-VFA only) increased EUR 9m to EUR -1,538m <sup>p. 43</sup>.
** ''Reserves at locked-in rate'' (FY24) at EUR 62bn with a liability book yield of 2.5% <sup>p. 43</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Technical and financial results in Euro million, pre-tax <sup>p. 43</sup>
!
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | +60
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | +156
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | -1
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | -9
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings bridge in Euro million <sup>p. 43</sup>
!
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying
| style="text-align:right" | 4,229
| style="text-align:right" | +205
Line 1,502 ⟶ 1,635:
| style="text-align:left" | Tax
| style="text-align:right" | -800
| style="text-align:right" |
|-
| style="text-align:left" | Affiliates, Minority interests & Other
Line 1,508 ⟶ 1,641:
| style="text-align:right" | -51
|-
| style="text-align:left" | Underlying
| style="text-align:right" | 3,501
| style="text-align:right" | +219
Line 1,514 ⟶ 1,647:
</div>
* ''Underlying earnings
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life & Health FY25 CSM key sensitivities in Euro billion <sup>p. 43</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Baseline
Line 1,592 ⟶ 1,662:
|-
| style="text-align:left" | Interest rates -50bps
| style="text-align:right" |
|-
| style="text-align:left" | Sovereign spreads +50bps
Line 1,598 ⟶ 1,668:
|-
| style="text-align:left" | Sovereign spreads -50bps
| style="text-align:right" |
|-
| style="text-align:left" | Corporate spread +50bps
Line 1,604 ⟶ 1,674:
|-
| style="text-align:left" | Corporate spread -50bps
| style="text-align:right" |
|-
| style="text-align:left" | Equities +25%
| style="text-align:right" |
|-
| style="text-align:left" | Equities -25%
Line 1,614 ⟶ 1,684:
</div>
=== Table of contents ===
* ''Sustainability'' <sup>p. 44</sup>
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
Line 1,624 ⟶ 1,695:
<div style="overflow-x:auto">
{| class="wikitable"
|+
! style="text-align:left" | Category
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" |
|-
| style="text-align:left" | Climate transition financing
Line 1,637 ⟶ 1,708:
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" | Transition underwriting
| class="col-m" style="text-align:right" | EUR 6bn in P&C GWP
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" | Climate adaptation solutions
| class="col-m" style="text-align:right" | >20,000
| class="col-m" style="text-align:right" | 19,698 (cumulative 2024-2025)
|-
Line 1,649 ⟶ 1,720:
| class="col-m" style="text-align:right" | 20.6m
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | >80,000 employees by 2026
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | -50% by 2030
| class="col-m" style="text-align:right" | -64%
|-
| style="text-align:left" | Employee volunteering
| class="col-m" style="text-align:right" | 50% of employees by 2026
| class="col-m" style="text-align:right" | 56%
|}
Line 1,667 ⟶ 1,738:
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG ratings
! style="text-align:left" | Rating Agency
! class="col-
|-
| style="text-align:left" | S&P Global percentile
| class="col-
|-
| style="text-align:left" | MSCI
| class="col-
|-
| style="text-align:left" | CDP
| class="col-
|-
| style="text-align:left" | Morningstar Sustainalytics
| class="col-
|-
| style="text-align:left" | FTSE Russell
| class="col-
|}
</div>
* The Corporate Sustainability Assessment (CSA) ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>.
* ''Morningstar Sustainalytics rating'': 2025 ESG Risk Rating of 17.0 – Low risk <sup>p. 46</sup>
* ''FTSE Russell score'': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
=== Scope ===
*
*
*
*
**
**
**
**
*
*
*
=== Glossary ===
*
*
*
*
*
*
*
*
*
*
*
*
*
=== February 26, 2026 Thank you Full Year 2025 earnings ===
* ''Closing slide'' for the AXA Full Year 2025 Earnings presentation,
== Abbreviations ==
*
*
*
* ''AEP'': Aggregate Exceedance Probability
* ''
* ''AMF'': Autorité des marchés financiers
* ''
* ''
* ''AXA XL'': AXA Corporate Solutions and XL Catlin
* ''
* ''
* ''
* ''
* ''
* ''
* ''
* ''
* ''DPS'': Dividend Per Share
* ''
* ''
* ''
* ''ESG'': Environmental, Social, and Governance
* ''ESMA'': European Securities and Markets Authority
* ''
* ''
* ''
* ''GAAP'': Generally Accepted Accounting Principles
* ''GBP'': Great British Pound
* ''
* ''
* ''
* ''
* ''
* ''IFRS'': International Financial Reporting Standards
* ''
* ''JPY'': Japanese Yen
* ''
* ''LFL'': Like-for-Like
* ''
* ''MSCI'': Morgan Stanley Capital International
* ''
* ''NB CSM'': New Business Contractual Service Margin
* ''
* ''
* ''
* ''
* ''PAA'': Participating Account Agreement
* ''PE'': Private Equity
* ''
* ''
* ''
* ''
* ''
* ''
* ''SME'': Small and Medium-sized Enterprises
* ''TVOG'': Time Value of Options and Guarantees
* ''UEPS'': Underlying Earnings Per Share
* ''UK'': United Kingdom
* ''US'': United States
* ''VAT'': Value Added Tax
* ''VFA'': Variable Fee Approach
| |||